Advancing Oncology: Immune Checkpoint Inhibitors Market Research

agregó una foto Health

2026-01-22 11:40:43 - Translate -

As of early 2026, the field of immuno-oncology has transitioned from a promising frontier to a dominant pillar of cancer care. High-level research is currently centered on identifying precise biomarkers to improve patient response rates, which typically range between 20% and 40% for single-agent therapies. By utilizing advanced genomic sequencing and AI-driven data analysis, scientists are now...

0 Commentarios 0 Acciones 734 Views 0 Vista previa